Otsuka ties up with Denmark's Lundbeck on psychiatric drugs
TOKYO, Japan - Otsuka Pharmaceutical Co. President Taro Iwamoto and Danish drugmaker H. Lundbeck A/S CEO Ulf Wiinberg shake hands in Tokyo on Nov. 11, 2011. The two companies agreed to share costs to develop and market drugs to treat central neurological diseases including schizophrenia. (Kyodo)
- Product Code
- ILEA000326939
- Registered date
- 2011/11/11 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media size
- 1414 × 1303 pixel
- Deployment size
- 433.85(KB)*
*File size when opened in Photoshop, etc.